Strong Revenue Growth
EXL reported revenue of $514 million in Q2 2025, an increase of 15% year-over-year. The adjusted EPS grew by 20% to $0.49 per share.
Health Care and Life Sciences Segment Growth
The health care and life sciences segment reported revenue of $129.5 million, representing growth of 22% year-over-year, driven by higher volumes in payment services and expansion in existing client relationships.
Data and AI-Led Revenue Surge
Data and AI-led revenue increased 17% year-over-year, growing to 54% of total revenue.
International Growth Markets Expansion
The international growth markets segment generated revenue of $91.7 million, up 15% year-over-year.
Raising Full-Year Revenue and EPS Guidance
EXL raised its full-year revenue and EPS guidance, anticipating 2025 revenue to be in the range of $2.05 billion to $2.07 billion, representing year-over-year growth of 12% to 13%.